Clinical Trials Browser

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease, Recurrence

Cholangiocarcinoma

Biliary Tract Neoplasms

Ovarian Neoplasms

Phase 2 Study

Carcinoma, Transitional Cell

Triple Negative Breast Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Transitional Cell

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms

Renal Pelvis and Ureter Urothelial Carcinoma

Neoplasm Metastasis, Neoplasms

Neoplasm Metastasis

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis

Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Uterine Cervical Neoplasms

Leiomyosarcoma, Liposarcoma, Sarcoma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

Nasopharyngeal Carcinoma

Neoplasm Metastasis

Pancreatic Adenocarcinoma

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Biliary Tract Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Lymphoma, Large B-Cell, Diffuse

Lung Neoplasms

Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Nasopharyngeal Neoplasms

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Lymphoma, T-Cell, Peripheral

Uterine Cervical Neoplasms

Pancreatic Neoplasms

Clinical Trials

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

DESTINY-BTC01

MAESTRA 2

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care

ADAPT-BLADDER

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

A Study of ASP3082 in Adults With Advanced Solid Tumors

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

INTerpath-009

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

TroFuse-019

MoonRISe-1

IMGeS

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

TroFuse-020

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

TroFuse-011

ASPEN-09-03

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

LIGHT

SWITCH

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

OLYMPIA-4

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

MUIR

waveLINE-003

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer

GAIN-BCG

TRANSPARENT

TERZO

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

RASolute 303